Our data show that GSK-3β inhibition by Tideglusib was accompanied by a significant reduction of the enhanced phosphorylation of TDP-43 protein, observed in ALS lymphoblasts as compared with cells derived from control individuals. The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.